Valacyclovir

Among patients with COPD and sputum Epstein-Barr virus, valaciclovir three times a day for 8 weeks helped more individuals suppress the virus than placebo, according to study results published in CHEST.

CHICAGO — For patients with advanced non-small cell lung cancer who showed an inadequate response to front-line immunotherapy checkpoint inhibitors and chemotherapy, the addition of CAN-2409 was well-tolerated.

WAIKOLOA, Hawaii — A presenter at Hawaiian Eye 2022 offered his list of considerations for performing cataract surgery in patients with herpetic disease.

ORLANDO — The novel antiviral agent letermovir appeared effective for primary cytomegalovirus prevention among haploidentical stem cell transplant recipients, according to results of a single-center chart review presented at TCT | Transplantation & Cellular Therapy Meetings.

WASHINGTON — Findings from a randomized, double-blind, placebo-controlled trial presented at IDWeek sparked hope for the use of antiviral medications, specifically valacyclovir, for the prevention of congenital cytomegalovirus, or CMV, infection.